These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12648468)

  • 1. ErbBs in mammary development.
    Stern DF
    Exp Cell Res; 2003 Mar; 284(1):89-98. PubMed ID: 12648468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF-related peptides and their receptors in mammary gland development.
    DiAugustine RP; Richards RG; Sebastian J
    J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):109-17. PubMed ID: 10882297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.
    Morato A; Accornero P; Hovey RC
    J Mammary Gland Biol Neoplasia; 2023 May; 28(1):10. PubMed ID: 37219601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland.
    Carraway KL; Carraway CA; Carraway KL
    J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):187-98. PubMed ID: 10882304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinases in mammary gland development and cancer.
    Kumar R; Wang RA
    Microsc Res Tech; 2002 Oct; 59(1):49-57. PubMed ID: 12242696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal growth is impeded in mammary glands of C-neu transgenic mice.
    Mukherjee S; Louie SG; Campbell M; Esserman L; Shyamala G
    Oncogene; 2000 Dec; 19(52):5982-7. PubMed ID: 11146549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation.
    Jones FE; Stern DF
    Oncogene; 1999 Jun; 18(23):3481-90. PubMed ID: 10376526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic expression of Erbb pathway members during early mammary gland morphogenesis.
    Wansbury O; Panchal H; James M; Parry S; Ashworth A; Howard B
    J Invest Dermatol; 2008 Apr; 128(4):1009-21. PubMed ID: 17960183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells.
    Darcy KM; Zangani D; Wohlhueter AL; Huang RY; Vaughan MM; Russell JA; Ip MM
    J Histochem Cytochem; 2000 Jan; 48(1):63-80. PubMed ID: 10653587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.